Cargando…
Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report
BACKGROUND: Preterm birth accounts for about 12% of all pregnancies worldwide and is the leading cause of neonatal morbidity and mortality. In order to avoid premature birth and prolong gestational age, tocolytics are the first and the best choice. Ritodrine is the most commonly used tocolytic medic...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855204/ https://www.ncbi.nlm.nih.gov/pubmed/35211573 http://dx.doi.org/10.12998/wjcc.v10.i4.1381 |
_version_ | 1784653605574279168 |
---|---|
author | Liu, Wen-Yu Zhang, Jia-Rong Xu, Xian-Ming Ye, Tian-Yi |
author_facet | Liu, Wen-Yu Zhang, Jia-Rong Xu, Xian-Ming Ye, Tian-Yi |
author_sort | Liu, Wen-Yu |
collection | PubMed |
description | BACKGROUND: Preterm birth accounts for about 12% of all pregnancies worldwide and is the leading cause of neonatal morbidity and mortality. In order to avoid premature birth and prolong gestational age, tocolytics are the first and the best choice. Ritodrine is the most commonly used tocolytic medication. However, side effects such as pulmonary edema, hypokalemia, and hyperglycemia are known. Here we report a rare but serious side effect–toxic epidermal necrolysis (TEN)–caused by ritodrine. CASE SUMMARY: A woman (31 years, gravida 4, para 2) was hospitalized because of premature contractions at 27 + 6 wk of gestation. A skin rash with pruritus appeared at 32 + 3 wk of gestation after administration of ritodrine, indomethacin, and dexamethasone, and it spread throughout the whole body in 3 d, particularly the four limbs. After 11 d’ treatment, she was diagnosed with TEN. An emergency cesarean section was performed immediately to deliver the baby and intensive symptomatic treatment was promptly commenced after delivery. She recovered from the severe condition without any sequelae except for slight pigmentation after symptomatic treatment. CONCLUSION: When a skin rash appears during the administration of ritodrine, we are supposed to consider the risk of TEN. |
format | Online Article Text |
id | pubmed-8855204 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-88552042022-02-23 Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report Liu, Wen-Yu Zhang, Jia-Rong Xu, Xian-Ming Ye, Tian-Yi World J Clin Cases Case Report BACKGROUND: Preterm birth accounts for about 12% of all pregnancies worldwide and is the leading cause of neonatal morbidity and mortality. In order to avoid premature birth and prolong gestational age, tocolytics are the first and the best choice. Ritodrine is the most commonly used tocolytic medication. However, side effects such as pulmonary edema, hypokalemia, and hyperglycemia are known. Here we report a rare but serious side effect–toxic epidermal necrolysis (TEN)–caused by ritodrine. CASE SUMMARY: A woman (31 years, gravida 4, para 2) was hospitalized because of premature contractions at 27 + 6 wk of gestation. A skin rash with pruritus appeared at 32 + 3 wk of gestation after administration of ritodrine, indomethacin, and dexamethasone, and it spread throughout the whole body in 3 d, particularly the four limbs. After 11 d’ treatment, she was diagnosed with TEN. An emergency cesarean section was performed immediately to deliver the baby and intensive symptomatic treatment was promptly commenced after delivery. She recovered from the severe condition without any sequelae except for slight pigmentation after symptomatic treatment. CONCLUSION: When a skin rash appears during the administration of ritodrine, we are supposed to consider the risk of TEN. Baishideng Publishing Group Inc 2022-02-06 2022-02-06 /pmc/articles/PMC8855204/ /pubmed/35211573 http://dx.doi.org/10.12998/wjcc.v10.i4.1381 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
spellingShingle | Case Report Liu, Wen-Yu Zhang, Jia-Rong Xu, Xian-Ming Ye, Tian-Yi Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report |
title | Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report |
title_full | Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report |
title_fullStr | Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report |
title_full_unstemmed | Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report |
title_short | Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report |
title_sort | toxic epidermal necrolysis induced by ritodrine in pregnancy: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855204/ https://www.ncbi.nlm.nih.gov/pubmed/35211573 http://dx.doi.org/10.12998/wjcc.v10.i4.1381 |
work_keys_str_mv | AT liuwenyu toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport AT zhangjiarong toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport AT xuxianming toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport AT yetianyi toxicepidermalnecrolysisinducedbyritodrineinpregnancyacasereport |